Nat Ricciardi
Director/Board Member at RAPID MICRO BIOSYSTEMS, INC.
Net worth: 2 M $ as of 2024-03-30
Profile
Natale S.
Ricciardi is an Independent Director at Prestige Consumer Healthcare, Inc. and Rapid Micro Biosystems, Inc. He is also an advisor and Board Member at Healthcare Royalty Management LLC.
Additionally, he is a Member of The City College 21st Century Foundation, Inc. In the past, he served as a Director at Mediacom Communications Corp.
from 2000 to 2011.
He was also an Independent Director at Dynavax Technologies Corp., Asterias Biotherapeutics, Inc., and Nuron Biotech, Inc. Furthermore, he held positions at Pfizer Inc. as a Senior Vice President from 2004 to 2011 and at Zoetis, Inc. as a Vice President-Manufacturing from 1995 to 1999.
He was the President of Pfizer Global Manufacturing from 2004 to 2011.
Mr. Ricciardi received his undergraduate degree from City University of New York and his MBA from Fordham University.
Current Job(s): Independent Director at Prestige Consumer Healthcare, Inc., Independent Director at Rapid Micro Biosystems, Inc., Advisor and Board Member at Healthcare Royalty Management LLC, Member of The City College 21st Century Foundation, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-07-31 | 27,098 ( 0.05% ) | 2 M $ | 2024-03-30 | |
| 2024-03-27 | 0 ( -.--% ) | - $ | 2024-03-30 |
Nat Ricciardi active positions
| Companies | Position | Start |
|---|---|---|
| RAPID MICRO BIOSYSTEMS, INC. | Director/Board Member | 2016-03-14 |
| PRESTIGE CONSUMER HEALTHCARE INC. | Director/Board Member | 2016-05-25 |
| The City College 21st Century Foundation, Inc. | Corporate Officer/Principal | - |
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Director/Board Member | 2012-12-31 |
Former positions of Nat Ricciardi
| Companies | Position | End |
|---|---|---|
| ASTERIAS BIOTHERAPEUTICS INC | Director/Board Member | 2019-03-07 |
Mediacom Communications Corp.
 Mediacom Communications Corp. Cable/Satellite TVConsumer Services Mediacom Communications Corp. provides cable and Internet access services. Its products include Xtream, television, internet, phone, and home security. The company was founded by Rocco B. Commisso in 1995 and is headquartered in Chester, NY. | Director/Board Member | 2010-12-31 |
| PFIZER, INC. | Private Equity Investor | 2010-12-31 |
| Pfizer Global Manufacturing | President | 2010-12-31 |
| ZOETIS INC. | Corporate Officer/Principal | 1998-12-31 |
Training of Nat Ricciardi
| City University of New York | Undergraduate Degree |
| Fordham University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| PFIZER, INC. | Health Technology |
| DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
| PRESTIGE CONSUMER HEALTHCARE INC. | Health Technology |
| RAPID MICRO BIOSYSTEMS, INC. | Producer Manufacturing |
| ZOETIS INC. | Health Technology |
| Private companies | 7 |
|---|---|
Mediacom Communications Corp.
Mediacom Communications Corp. Cable/Satellite TVConsumer Services Mediacom Communications Corp. provides cable and Internet access services. Its products include Xtream, television, internet, phone, and home security. The company was founded by Rocco B. Commisso in 1995 and is headquartered in Chester, NY. | Consumer Services |
Asterias Biotherapeutics, Inc.
 Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
National Association of Manufacturers
 National Association of Manufacturers Miscellaneous Commercial ServicesCommercial Services The National Association of Manufacturers is an organization that works for the success of over 12.9 million people who are involved in manufacturing. The non-profit company is based in Washington and has subsidiaries in the United States. The American company's work is based on four core values that drive the industry. The company commissioned a study in August 2015, which found that the EPA's proposed ozone rule could reduce GDP by $140 billion. The CEO of the company is Jay Timmons. | Commercial Services |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Finance |
| The City College 21st Century Foundation, Inc. | |
Nuron Biotech, Inc.
 Nuron Biotech, Inc. BiotechnologyHealth Technology Nuron Biotech, Inc. markets and develops vaccines for the prevention and treatment of infectious diseases. It develops novel biologics and vaccines for the prevention and treatment of neurodegenerative and infectious diseases. The firm is advancing products to meet unmet medical needs in the areas of multiple sclerosis, alzheimer's, hepatitis b and hepatitis c for patients across the globe. The company was founded by Vithalbhai Dhaduk, Shankar Musunuri and David Zeng in 2009 and is headquartered in Exton, PA. | Health Technology |
| Pfizer Global Manufacturing |
- Stock Market
- Insiders
- Nat Ricciardi
